Related Experiment Videos
Effects of phenobarbital on early intellectual and behavioral development: a concordant twin case study
Insights
This study on twins suggests early phenobarbital treatment for febrile seizures may temporarily impact cognitive development and behavior in children, with effects resolving after discontinuation.
Area of Science:
- Pediatric Neurology
- Developmental Psychology
- Pharmacology
Background:
- Febrile seizures are common in young children.
- Phenobarbital is a medication sometimes used to manage seizures.
- The long-term effects of early phenobarbital exposure on neurodevelopment require further investigation.
Purpose of the Study:
- To investigate the potential impact of early phenobarbital treatment on intellectual and behavioral development.
- To compare neurodevelopmental outcomes between a treated twin and an untreated twin.
Main Methods:
- A case study involving a monozygotic twin pair discordant for phenobarbital treatment for febrile seizures.
- Standardized intellectual and behavioral assessments administered longitudinally from 30 months to 66 months of age.
- Comparison of developmental trajectories between the treated and untreated twin.
Main Results:
- Both twins exhibited normal global intelligence, but the phenobarbital-exposed twin consistently scored lower on cognitive assessments.
- Subtle differences in specific cognitive abilities were observed post-treatment.
- The treated twin demonstrated immediate behavioral improvement upon phenobarbital withdrawal.
Conclusions:
- Early phenobarbital treatment may have a transient, non-severe negative effect on global intelligence during the preschool years.
- Phenobarbital exposure might adversely affect behavior, with effects reversible upon drug cessation.
- This case highlights the importance of monitoring neurodevelopmental outcomes in infants treated with phenobarbital.
Abstract:
A Monozygotic twin pair had febrile seizures, only one was treated with phenobarbital from 17-30 months of age. Standard intellectual and behavioral assessments were conducted during Treatment (30 months of age), and Post-Treatment (32, 41, 48, 66 months of age). Both twins showed normal global intelligence at all assessments, however, the phenobarbital twin scored lower at all assessments. Differences in specific abilities were also seen during Post-Treatment. When phenobarbital was withdrawn, the treated twin's behavior showed immediate improvement. This experience suggests that early phenobarbital treatment may affect global intelligence through the preschool period, but that the effect is not severe. Phenobarbital also may adversely affect behavior, although the effect disappears with termination of the drug.